76 related articles for article (PubMed ID: 12136932)
1. TEL/JAK2 tyrosine kinase inhibits DNA repair in the presence of amifostine.
Gloc E; Warszawski M; Młynarski W; Stolarska M; Hoser G; Skorski T; Błasiak J
Acta Biochim Pol; 2002; 49(1):121-8. PubMed ID: 12136932
[TBL] [Abstract][Full Text] [Related]
2. ABL-fusion oncoproteins activate multi-pathway of DNA repair: role in drug resistance?
Majsterek I; Slupianek A; Hoser G; Skórski T; Blasiak J
Biochimie; 2004 Jan; 86(1):53-65. PubMed ID: 14987801
[TBL] [Abstract][Full Text] [Related]
3. Amifostine differentially modulates DNA damage evoked by idarubicin in normal and leukemic cells.
Błasiak J; Gloc E; Młynarski W; Drzewoski J; Skórski T
Leuk Res; 2002 Dec; 26(12):1093-6. PubMed ID: 12443881
[TBL] [Abstract][Full Text] [Related]
4. Amifostine can differentially modulate DNA double-strand breaks and apoptosis induced by idarubicin in normal and cancer cells.
Wozniak K; Gloc E; Morawiec Z; Blasiak J
Exp Oncol; 2008 Mar; 30(1):22-8. PubMed ID: 18438337
[TBL] [Abstract][Full Text] [Related]
5. Genotoxicity of idarubicin and its modulation by vitamins C and E and amifostine.
Błasiak J; Gloc E; Woźniak K; Młynarski W; Stolarska M; Skórski T; Majsterek I
Chem Biol Interact; 2002 Apr; 140(1):1-18. PubMed ID: 12044557
[TBL] [Abstract][Full Text] [Related]
6. Does the bcr/abl-mediated increase in the efficacy of DNA repair play a role in the drug resistance of cancer cells?
Majsterek I; Blasiak J; Mlynarski W; Hoser G; Skórski T
Cell Biol Int; 2002; 26(4):363-70. PubMed ID: 11991666
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the action of amifostine and melatonin on DNA-damaging effects and apoptosis induced by idarubicin in normal and cancer cells.
Majsterek I; Gloc E; Blasiak J; Reiter RJ
J Pineal Res; 2005 May; 38(4):254-63. PubMed ID: 15813902
[TBL] [Abstract][Full Text] [Related]
8. Licochalcone A is a potent inhibitor of TEL-Jak2-mediated transformation through the specific inhibition of Stat3 activation.
Funakoshi-Tago M; Tago K; Nishizawa C; Takahashi K; Mashino T; Iwata S; Inoue H; Sonoda Y; Kasahara T
Biochem Pharmacol; 2008 Dec; 76(12):1681-93. PubMed ID: 18848530
[TBL] [Abstract][Full Text] [Related]
9. TEL-fusion oncogenic tyrosine kinases determine leukemic cells response to idarubicin.
Majsterek I; Slupianek A; Blasiak J
Anticancer Drugs; 2003 Sep; 14(8):625-31. PubMed ID: 14501384
[TBL] [Abstract][Full Text] [Related]
10. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J
Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976
[TBL] [Abstract][Full Text] [Related]
11. Fusion oncogenic tyrosine kinases alter DNA damage and repair after genotoxic treatment: role in drug resistance?
Hoser G; Majsterek I; Romana DL; Slupianek A; Blasiak J; Skorski T
Leuk Res; 2003 Mar; 27(3):267-73. PubMed ID: 12537980
[TBL] [Abstract][Full Text] [Related]
12. DNA damage and repair in BCR/ABL-expressing cells after combined action of idarubicin, STI571 and amifostine.
Blasiak J; Gloc E; Pertyński T; Drzewoski J
Anticancer Drugs; 2002 Nov; 13(10):1055-60. PubMed ID: 12439339
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the in vitro genotoxicity of anticancer drugs idarubicin and mitoxantrone.
Błasiak J; Gloc E; Warszawski M
Acta Biochim Pol; 2002; 49(1):145-55. PubMed ID: 12136935
[TBL] [Abstract][Full Text] [Related]
14. The DNA-damaging potential of tamoxifen in breast cancer and normal cells.
Wozniak K; Kolacinska A; Blasinska-Morawiec M; Morawiec-Bajda A; Morawiec Z; Zadrozny M; Blasiak J
Arch Toxicol; 2007 Jul; 81(7):519-27. PubMed ID: 17593413
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein.
Sjöblom T; Boureux A; Rönnstrand L; Heldin CH; Ghysdael J; Ostman A
Oncogene; 1999 Nov; 18(50):7055-62. PubMed ID: 10597306
[TBL] [Abstract][Full Text] [Related]
16. A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.
Sattler M; Pride YB; Ma P; Gramlich JL; Chu SC; Quinnan LA; Shirazian S; Liang C; Podar K; Christensen JG; Salgia R
Cancer Res; 2003 Sep; 63(17):5462-9. PubMed ID: 14500382
[TBL] [Abstract][Full Text] [Related]
17. High levels of chromosome aberrations correlate with impaired in vitro radiation-induced apoptosis and DNA repair in human B-chronic lymphocytic leukaemia cells.
Blaise R; Alapetite C; Masdehors P; Merle-Beral H; Roulin C; Delic J; Sabatier L
Int J Radiat Biol; 2002 Aug; 78(8):671-9. PubMed ID: 12194750
[TBL] [Abstract][Full Text] [Related]
18. Amifostine protection against induced DNA damage in gamma-irradiated Escherichia coli cells depend on recN DNA repair gene product activity.
Almeida E; Fuentes JL; Cuetara E; Prieto E; Llagostera M
Environ Toxicol; 2010 Apr; 25(2):130-6. PubMed ID: 19399845
[TBL] [Abstract][Full Text] [Related]
19. Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis.
Slupianek A; Hoser G; Majsterek I; Bronisz A; Malecki M; Blasiak J; Fishel R; Skorski T
Mol Cell Biol; 2002 Jun; 22(12):4189-201. PubMed ID: 12024032
[TBL] [Abstract][Full Text] [Related]
20. Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes.
Czechowska A; Poplawski T; Drzewoski J; Blasiak J
Chem Biol Interact; 2005 Apr; 152(2-3):139-50. PubMed ID: 15840387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
